Compile Data Set for Download or QSAR
Report error Found 10 Enz. Inhib. hit(s) with all data for entry = 6935
LigandPNGBDBM160544(US9040717, Compound (3))
Affinity DataIC50: 3.5nMpH: 8.0Assay Description:For expression of hPDHK1 activity, Escherichia coli strain BL21(DE3) cells (Novagen) were transformed with the pET17b vector containing modified hPDH...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2015
Entry Details
US Patent

LigandPNGBDBM160544(US9040717, Compound (3))
Affinity DataIC50: 4.20nMpH: 8.0 T: 2°CAssay Description:For expression of hPDHK2 activity, Escherichia coli strain BL21(DE3) cells (Novagen) were transformed with the pET17b vector containing modified hPDH...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2015
Entry Details
US Patent

LigandPNGBDBM160542(US9040717, Compound (2h) | US9040717, Compound (2))
Affinity DataIC50: 4.60nMpH: 8.0 T: 2°CAssay Description:For expression of hPDHK2 activity, Escherichia coli strain BL21(DE3) cells (Novagen) were transformed with the pET17b vector containing modified hPDH...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2015
Entry Details
US Patent

LigandPNGBDBM160542(US9040717, Compound (2h) | US9040717, Compound (2))
Affinity DataIC50: 4.70nMpH: 8.0Assay Description:For expression of hPDHK1 activity, Escherichia coli strain BL21(DE3) cells (Novagen) were transformed with the pET17b vector containing modified hPDH...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2015
Entry Details
US Patent

LigandPNGBDBM160542(US9040717, Compound (2h) | US9040717, Compound (2))
Affinity DataIC50: 4.90nMpH: 8.0 T: 2°CAssay Description:For expression of hPDHK2 activity, Escherichia coli strain BL21(DE3) cells (Novagen) were transformed with the pET17b vector containing modified hPDH...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2015
Entry Details
US Patent

LigandPNGBDBM160541(US9040717, Compound (D))
Affinity DataIC50: 5.10nMpH: 8.0 T: 2°CAssay Description:For expression of hPDHK2 activity, Escherichia coli strain BL21(DE3) cells (Novagen) were transformed with the pET17b vector containing modified hPDH...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2015
Entry Details
US Patent

LigandPNGBDBM160538(US9040717, Compound (A))
Affinity DataIC50: 5.10nMpH: 8.0 T: 2°CAssay Description:For expression of hPDHK2 activity, Escherichia coli strain BL21(DE3) cells (Novagen) were transformed with the pET17b vector containing modified hPDH...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2015
Entry Details
US Patent

LigandPNGBDBM160542(US9040717, Compound (2h) | US9040717, Compound (2))
Affinity DataIC50: 6.60nMpH: 8.0Assay Description:For expression of hPDHK1 activity, Escherichia coli strain BL21(DE3) cells (Novagen) were transformed with the pET17b vector containing modified hPDH...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2015
Entry Details
US Patent

LigandPNGBDBM160540(US9040717, Compound (C))
Affinity DataIC50: 6.70nMpH: 8.0 T: 2°CAssay Description:For expression of hPDHK2 activity, Escherichia coli strain BL21(DE3) cells (Novagen) were transformed with the pET17b vector containing modified hPDH...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2015
Entry Details
US Patent

LigandPNGBDBM160539(US9040717, Compound (B))
Affinity DataIC50: 7.40nMpH: 8.0 T: 2°CAssay Description:For expression of hPDHK2 activity, Escherichia coli strain BL21(DE3) cells (Novagen) were transformed with the pET17b vector containing modified hPDH...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2015
Entry Details
US Patent